Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
Takahiro ShimoyamaTakayuki YamamotoShigeyuki YoshiyamaRyutaro NishikawaSatoru UmegaePublished in: Inflammatory bowel diseases (2022)
Leucine-rich alpha-2 glycoprotein is a reliable serum biomarker for the assessment of clinical and endoscopic disease activity in patients with IBD. It can be an alternative to CRP for the assessment of UC.